- Home
- DYN vs ACLS Comparison
DYN vs ACLS Comparison
Compare DYN & ACLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- ACLS
- Stock Information
- Founded
- DYN 1984
- ACLS 1995
- Country
- DYN United States
- ACLS United States
- Employees
- DYN N/A
- ACLS N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- ACLS Industrial Machinery/Components
- Sector
- DYN Health Care
- ACLS Technology
- Exchange
- DYN Nasdaq
- ACLS Nasdaq
- Market Cap
- DYN 1.9B
- ACLS 2.2B
- IPO Year
- DYN 2020
- ACLS 2000
- Fundamental
- Price
- DYN $14.22
- ACLS $80.61
- Analyst Decision
- DYN Strong Buy
- ACLS Buy
- Analyst Count
- DYN 14
- ACLS 5
- Target Price
- DYN $34.93
- ACLS $90.00
- AVG Volume (30 Days)
- DYN 2.4M
- ACLS 450.4K
- Earning Date
- DYN 07-28-2025
- ACLS 08-05-2025
- Dividend Yield
- DYN N/A
- ACLS N/A
- EPS Growth
- DYN N/A
- ACLS N/A
- EPS
- DYN N/A
- ACLS 4.91
- Revenue
- DYN N/A
- ACLS $896,089,000.00
- Revenue This Year
- DYN N/A
- ACLS N/A
- Revenue Next Year
- DYN N/A
- ACLS $5.27
- P/E Ratio
- DYN N/A
- ACLS $16.42
- Revenue Growth
- DYN N/A
- ACLS N/A
- 52 Week Low
- DYN $6.36
- ACLS $40.40
- 52 Week High
- DYN $37.08
- ACLS $110.17
- Technical
- Relative Strength Index (RSI)
- DYN 73.48
- ACLS 55.67
- Support Level
- DYN $13.03
- ACLS $77.32
- Resistance Level
- DYN $13.85
- ACLS $80.17
- Average True Range (ATR)
- DYN 0.64
- ACLS 2.50
- MACD
- DYN 0.04
- ACLS -0.48
- Stochastic Oscillator
- DYN 95.55
- ACLS 55.65
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About ACLS Axcelis Technologies Inc.
Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.